N/A · Lord Abbett Private Credit Fund - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q1 '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - | - | - |
| SG&A | $188.0K | - | $65.0K | $66.0K | $71.0K | - | $59.0K | - |
| Total Operating Expenses | $15.83M | - | $12.53M | $3.38M | $8.14M | - | $71.0K | - |
| D&A | - | - | - | - | - | - | - | - |
| Operating Income | - | - | - | - | - | - | - | - |
| Interest Expense | $10.51M | - | $8.47M | $2.58M | $5.84M | - | $3.56M | - |
| Income Tax | - | - | - | - | - | - | - | - |
| Net Income | $8.41M | - | $12.08M | $2.60M | $7.16M | - | $4.03M | - |
| EPS - Basic | - | - | - | - | - | - | - | - |
| EPS - Diluted | - | - | - | - | $0.72 | - | - | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q1 '24 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $67.75M | $120.44M | $24.15M | $7.78M | $95.32M | $113.77M | $4.00M | $0 |
| Accounts Receivable | - | - | - | - | $453.0K | $81.0K | $101.0K | - |
| Inventory | - | - | - | - | - | - | - | - |
| Accounts Payable | - | - | - | - | - | - | - | - |
| Current Assets | - | - | $980.92M | $871.23M | $692.63M | $591.97M | $320.24M | - |
| Total Assets | $1.49B | $1.45B | - | - | - | $591.97M | - | - |
| Current Liabilities | - | - | - | - | - | - | - | - |
| Long-term Debt | $710.77M | - | $797.05M | - | - | $382.23M | - | - |
| Total Liabilities | $819.38M | $925.71M | $561.48M | $538.41M | $422.47M | $388.43M | $191.95M | - |
| Stockholders' Equity | - | - | - | - | - | - | - | - |
| Retained Earnings | ($9.34M) | ($525.0K) | - | - | - | $1.17M | - | - |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q1 '24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ($102.97M) | - | - | - | $112.19M | - | - | - |
| Investing Cash Flow | - | - | - | - | - | - | - | - |
| Financing Cash Flow | $50.09M | - | - | - | $93.75M | - | - | - |
| CapEx | - | - | - | - | - | - | $151.53M | - |
| Free Cash Flow | - | - | - | - | - | - | - | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q1 '24 |
|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||
| Gross margin | - | - | - | - | - | - | - | - |
| Operating margin | - | - | - | - | - | - | - | - |
| EBITDA margin | - | - | - | - | - | - | - | - |
| Net margin | - | - | - | - | - | - | - | - |
| Free cash flow margin | - | - | - | - | - | - | - | - |
| FCF / Net income | - | - | - | - | - | - | - | - |
| R&D / Revenue | - | - | - | - | - | - | - | - |
| SG&A / Revenue | - | - | - | - | - | - | - | - |
| Effective tax rate | - | - | - | - | - | - | - | - |
| Return on assets | 0.6% | - | - | - | - | - | - | - |
| Return on equity | - | - | - | - | - | - | - | - |
| Return on invested capital | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||
| Current ratio | - | - | - | - | - | - | - | - |
| Quick ratio | - | - | - | - | - | - | - | - |
| Cash ratio | - | - | - | - | - | - | - | - |
| Leverage | ||||||||
| Debt / Equity | - | - | - | - | - | - | - | - |
| Debt / Assets | 0.48 | - | - | - | - | 0.65 | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - |
| Interest coverage | - | - | - | - | - | - | - | - |
| Equity multiplier | - | - | - | - | - | - | - | - |
| Liabilities / Assets | 0.55 | 0.64 | - | - | - | 0.66 | - | - |
| Efficiency | ||||||||
| Asset turnover | - | - | - | - | - | - | - | - |
| Inventory turnover | - | - | - | - | - | - | - | - |
| Days sales outstanding | - | - | - | - | - | - | - | - |
| Days inventory outstanding | - | - | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - |
| Valuation | ||||||||
| P / E | - | - | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - | - | - |
| Growth | ||||||||
| Revenue growth (YoY) | - | - | - | - | - | - | - | - |
| Revenue CAGR (3y) | - | - | - | - | - | - | - | - |
| Revenue CAGR (5y) | - | - | - | - | - | - | - | - |
| Gross profit growth (YoY) | - | - | - | - | - | - | - | - |
| Operating income growth (YoY) | - | - | - | - | - | - | - | - |
| Net income growth (YoY) | 17.4% | - | 199.6% | - | - | - | - | - |
| EPS growth (YoY) | - | - | - | - | - | - | - | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | - | - | - | - | - | - | - | - |